1. The ACTION Study. (Slide presentation, Cardiovascular Research Foundation [CRF] Drug-Eluting Stent Symposium. Transcatheter Cardiovascular Therapeutics [TCTMD] online database) [accessed 31/10/2002];Linnemeier,2002
2. Final ACTION results (ActinomycinD) ACTinomycineluting stent improves outcomes by reducing neointimal hyperplasia -ACTION TCT 2002, Washington DC, September 25-28 [accessed 21/01/2003];Serruys,2002
3. Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial;Serruys;Journal of the American College of Cardiology,2004
4. Actinomycin eluting stent improves outcomes by reducing neointimal hyperplasia (ACTION);Serruys
5. Evaluation of a new polymer-coated paclitaxel-eluting stent for treatment of de novo lesions: Six-month clinical and angiographic follow-up results of the APPLAUSE trial;Grube;Journal of Invasive Cardiology,2006